Early trial results found median survival nearly doubled in ovarian cancer patients with addition of Elenagen
After two years, patients receiving gemcitabine and Elenagen survived twice as long as those treated with chemotherapy alone.
US women prefer clinic to at-home screening for cervical cancer
Most American women prefer to have their cervical cancer screening done by a professional in a doctor’s office despite the availability of newly FDA-approved at-home screening kits.
Niraparib nearly doubles progression-free survival in prostate cancer with specific genetic mutations
Men with prostate cancer whose tumors have specific genetic mutations saw a nearly 50 percent reduction in the risk of cancer progression when they received naraparib.
Risk of anal cancer twice as high for cervical cancer survivors
Anoscopy is the direct visualization of the anus using a speculum. It is used to screen, diagnose, and evaluate perianal and anal...
Study shows two high-dose radiation sessions as effective as standard multi-session treatments for endometrial cancer
High-dose radiation uses of radiation tubes that produce radiation at a fast rate so that the treatment can be completed in minutes....
New drug improves survival in advanced ovarian cancer
CANCER DIGEST – June 24, 2023 – Nearly half of women with advanced ovarian cancer that is resistant to standard chemotherapy survived...
